Zavante Therapeutics Closes $45 Million Series A Financing In Support Of U.S. Development For A First-In-Class Injectable Antibiotic by longitudeadmin | Mar 30, 2016 | Portfolio News
Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT) by longitudeadmin | Mar 30, 2016 | Portfolio News
Venus Concept Receives Clearance by U.S. Food and Drug Administration for Venus Versa™ for over 20 Common Clinical Indications by longitudeadmin | Mar 24, 2016 | Portfolio News
Collegium Reports 2015 Financial Results and Provides Corporate Update by longitudeadmin | Mar 15, 2016 | Portfolio News
Rapid Micro Biosystems Appoints Natale “Nat” Ricciardi to Board of Directors by longitudeadmin | Mar 15, 2016 | Uncategorized
